Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.
Ross CJ; Katzov-Eckert H; Dubé MP; Brooks B; Rassekh SR; Barhdadi A; Feroz-Zada Y; Visscher H; Brown AM; Rieder MJ; Rogers PC; Phillips MS; Carleton BC; Hayden MR; Nature Genetics, 2009, vol. 41, issue 12, p 1345, ISSN 15461718. ISBN 15461718.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef